Press release
Future of Inhaler Corticosteroid Device Market: Size, Share & Forecasts to 2029
Inhaler Corticosteroid Device
What Is the Projected Market Size Valuation of the Inhaler Corticosteroid Device Market by 2025?
The market size for inhaler corticosteroid devices has seen robust growth in recent times. It is predicted to rise from $15.75 billion in 2024 to $16.83 billion in 2025, experiencing a compound annual growth rate (CAGR) of 6.9%. Factors contributing to growth during the historic period include enhanced healthcare spending, rising elderly population, favourable government regulations, relentless research and development efforts, and elevated disposable income.
What Is the Estimated Market Growth Value for the Inhaler Corticosteroid Device Industry in 2029?
In the coming years, the inhaler corticosteroid device market is anticipated to experience robust growth, reaching a market size of $21.77 billion in 2029, increasing at a compound annual growth rate (CAGR) of 6.6%. This projected growth within the forecast period is due to factors such as increased occurrence of respiratory conditions, heightened consciousness about respiratory health, substantial funding in respiratory technologies, sharpened focus on health enlightenment, and escalating smoking addiction. Key trends for this forecast period encompass the integration of sophisticated technologies, the formulation of combined treatments, the advent of digital inhalers delivering real-time data, advances in inhaler technology, and the application of data analysis in inhaler devices.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/inhaler-corticosteroid-device-global-market-report
What Are the Growth Drivers and Opportunities in the Inhaler Corticosteroid Device Market?
The inhaler corticosteroid device market is projected to grow due to the rising incidence of respiratory diseases. These diseases encompass a variety of conditions that affect lungs and airways, consequently causing issues in breathing efficiently and effectively. Respiratory diseases are on the rise due to increased air pollution, exposing people to harmful particles that result in lung damage and stimulate chronic conditions like asthma and bronchitis. Inhaler corticosteroid devices play a crucial role in treating these diseases by delivering anti-inflammatory medicine directly to the lungs to decrease inflammation and enhance breathing. For example, England noted 854,922 emergency hospital admissions for respiratory diseases during the financial year ending in 2024, as reported in June 2025 by the Office for Health Improvement and Disparities, a UK government department. This figure corresponds to a rate of 1,428 (ranging from 1,424 to 1,432) per 100,000 population, representing a 7% increase compared to the previous year. Hence, the upsurge in respiratory diseases' incidence drives the inhaler corticosteroid device market's growth.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25794&type=smp
What Are the Primary Segments Covered in the Global Inhaler Corticosteroid Device Market Report?
The inhaler corticosteroid device market covered in this report is segmented -
1) By Product Type: Metered-Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers
2) By Formulation Type: Fluticasone Propionate, Budesonide, Beclomethasone, Mometasone Furoate
3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Direct Sales, Hospital Pharmacies
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Other Applications
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Metered-Dose Inhalers: Conventional Metered-Dose Inhalers, Breath-Actuated Metered-Dose Inhalers, Spacer-Integrated Metered-Dose Inhalers
2) By Dry Powder Inhalers: Single-Dose Dry Powder Inhalers, Multi-Dose Dry Powder Inhalers, Reservoir Dry Powder Inhalers
3) By Soft Mist Inhalers: Manual Soft Mist Inhalers, Battery-Operated Soft Mist Inhalers
What Are the Top Growth Trends in the Inhaler Corticosteroid Device Market?
Leading businesses in the inhaler corticosteroid device market are shifting their focus to providing innovative solutions such as combined rescue inhalers of albuterol and budesonide. This shift aims to increase the effectiveness of treatment and provide dual-action therapy with a single device, making it more convenient for patients. An inhaler combining these two compounds brings together a bronchodilator (albuterol) to open airways promptly and a corticosteroid (budesonide) to mitigate inflammation. This combination offers quick symptomatic relief and long-term asthma control in one device. A perfect example of this innovation is AstraZeneca PLC, a UK pharmaceutical company that, in January 2024, launched AIRSUPRA - the first and only FDA-approved rescue inhaler combining albuterol and budesonide. Tailored for as-needed usage to alleviate acute bronchoconstriction symptoms and minimize airway inflammation, AIRSUPRA can significantly decrease the chances of severe asthma attacks. This unique approach, which brings together a short-acting beta2-agonist (albuterol) with an inhaled corticosteroid (budesonide) in one inhaler, has been approved by backing clinical trials that showcase its advantage over using albuterol alone in preventing asthma attacks.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25794&type=smp
Which Companies Are Shaping the Future of the Inhaler Corticosteroid Device Market?
Major companies operating in the inhaler corticosteroid device market are AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Teijin Pharma Limited, Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Mundipharma International Limited, Lupin Limited, Zydus Lifesciences Limited, Recipharm AB, Glenmark Pharmaceuticals Limited, Orion Corporation, Beximco Pharmaceuticals Limited, PARI Medical Holding GmbH, Kos Pharmaceuticals Inc.
Which Region Holds the Largest Market Share in the Inhaler Corticosteroid Device Industry?
North America was the largest region in the inhaler corticosteroid device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhaler corticosteroid device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future of Inhaler Corticosteroid Device Market: Size, Share & Forecasts to 2029 here
News-ID: 4157543 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Inhaler
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg
Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for…
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as…
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma…
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for…
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the…
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
